Sorrento Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
15 Nov 2022	Form 3: Sorrento Therapeutics, Inc., 10% owner · Scilex Holding Co Holds 135,726,590 shares of Common Stock
20 May 2022	Form 3: Reilly Tammy, Director No securities owned
18 Nov 2021	Form 3: Czerepak Elizabeth, Director No securities owned
23 Jul 2021	Form 3: Sorrento Therapeutics, Inc., 10% owner · Celularity Inc Holds 20,422,124 shares of Class A Common Stock
21 Aug 2020	Form 3: Asghar Najjam, Chief Financial Officer
18 Dec 2019	Form 3: Smith Robin L, Director Holds 20,000 shares of Common Stock
11 Dec 2019	Form 3: Lee Edgar, Director No securities owned
19 Mar 2018	Form 3: Shao Jiong, Chief Financial Officer
02 Oct 2017	Form 3: Lemus David, Director No securities owned
02 Oct 2017	Form 3: Followwill Dorman, Director Holds 2,130 shares of Common Stock
19 May 2017	Form 3: Ferrigno Dean, Chief Accounting Officer Holds 63 shares of Common Stock
03 May 2017	Form 3: Asia Pacific MedTech (BVI) Ltd, 10% owner and 1 other Holds 9,301,801 shares of Common Stock
15 Nov 2016	Form 3: Zeldis Jerome B, See Remarks No securities owned
05 Oct 2016	Form 3: Toledano Miranda Jayne, EVP-Corporate Development
17 Aug 2016	Form 3: Wu Yue Alexander, Director
15 Jul 2016	Form 3: Abg Management Ltd, 10% owner and 8 others Holds 397,853 shares of Common Stock, $0.0001 par value
08 Apr 2016	Form 3: Herde Kevin, Executive VP and CFO Holds 4,000 shares of Common Stock
01 Mar 2016	Form 3: Chan Soon-Shiong Family Foundation, 10% owner Holds 7,188,061 shares of Common Stock
02 Nov 2015	Form 3: Su Jeffrey, Executive VP and COO Holds 9,000 shares of Common Stock
01 May 2015	Form 3: Deming David H, Director

Comments